Search Results

Filter
  • 1-10 of  4,804 results for ""Immune Checkpoint Inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer-Narrative Review.

  • Authors : Poniewierska-Baran A; Center of Experimental Immunology and Immunobiology of Infectious and Cancer Diseases, University of Szczecin, 71-417 Szczecin, Poland.; Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland.

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/immunology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 12; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment.

  • Authors : Shi X; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, China.

Subjects: B-Lymphocytes*/B-Lymphocytes*/B-Lymphocytes*/drug effects ; B-Lymphocytes*/B-Lymphocytes*/B-Lymphocytes*/immunology ; B-Lymphocytes*/B-Lymphocytes*/B-Lymphocytes*/metabolism

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Dec; Vol. 11 (47), pp. e2403423. Date of Electronic Publication: 2024 Nov 07.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

×
Academic Journal

Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics.

  • Authors : Ye Z; Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.; Li G

Subjects: Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/immunology ; Immune Checkpoint Proteins*/Immune Checkpoint Proteins*/Immune Checkpoint Proteins*/metabolism

  • Source: Experimental & molecular medicine [Exp Mol Med] 2024 Nov; Vol. 56 (11), pp. 2365-2381. Date of Electronic Publication: 2024 Nov 11.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Characterizing soluble immune checkpoint molecules and TGF-β 1,2,3 in pleural effusion of malignant pleural mesothelioma.

  • Authors : Okita R; Department of Thoracic Surgery, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan. .; Senoo T

Subjects: Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/metabolism ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/pathology ; Mesothelioma, Malignant*/Mesothelioma, Malignant*/Mesothelioma, Malignant*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Jul 10; Vol. 14 (1), pp. 15947. Date of Electronic Publication: 2024 Jul 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer.

  • Authors : Dermime S; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.

Subjects: Biomarkers, Tumor* ; Immune Checkpoint Proteins*/Immune Checkpoint Proteins*/Immune Checkpoint Proteins*/genetics ; Immune Checkpoint Proteins*/Immune Checkpoint Proteins*/Immune Checkpoint Proteins*/metabolism

  • Source: Frontiers in immunology [Front Immunol] 2021 Oct 21; Vol. 12, pp. 781872. Date of Electronic Publication: 2021 Oct 21 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection.

  • Authors : Righi I; Thoracic Surgery and Lung Transplantation Unit, Department of Cardio- Thoracic - Vascular Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.; Trabattoni D

Subjects: Graft Rejection*/Graft Rejection*/Graft Rejection*/immunology ; Graft Rejection*/Graft Rejection*/Graft Rejection*/prevention & control ; Organ Transplantation*/Organ Transplantation*/Organ Transplantation*/adverse effects

  • Source: Immunology letters [Immunol Lett] 2024 Jun; Vol. 267, pp. 106860. Date of Electronic Publication: 2024 Apr 25.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer.

  • Authors : Alemohammad H; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.; Najafzadeh B

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*pharmacology ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*pharmacology ; Immune Checkpoint Proteins/Immune Checkpoint Proteins/Immune Checkpoint Proteins/*metabolism

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Feb; Vol. 146, pp. 112516. Date of Electronic Publication: 2021 Dec 11.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.

  • Authors : Fathi M; Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran.; Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Subjects: Immune Checkpoint Inhibitors*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*therapy ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*therapy

  • Source: IUBMB life [IUBMB Life] 2021 May; Vol. 73 (5), pp. 726-738. Date of Electronic Publication: 2021 Mar 30.Publisher: Published for the International Union of Biochemistry and Molecular Biology by Taylor & Francis Country of Publication: England NLM ID: 100888706

Record details

×
Academic Journal

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers.

  • Authors : Li Y; Department of Radiotherapy, First Medical Center of Chinese PLA General Hospital, Beijing, China.; Oncology Laboratory, First Medical Center of Chinese PLA General Hospital, Beijing, China.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use ; Immune Checkpoint Proteins/Immune Checkpoint Proteins/Immune Checkpoint Proteins/*genetics

  • Source: Frontiers in immunology [Front Immunol] 2021 Jun 07; Vol. 12, pp. 649343. Date of Electronic Publication: 2021 Jun 07 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters.

  • Authors : Wang S; National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, China.; Xie K

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/adverse effects; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use ; Immune Checkpoint Proteins/Immune Checkpoint Proteins/Immune Checkpoint Proteins/*metabolism

  • Source: Frontiers in immunology [Front Immunol] 2021 Jul 21; Vol. 12, pp. 690112. Date of Electronic Publication: 2021 Jul 21 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  4,804 results for ""Immune Checkpoint Inhibitors""